ily Foundation had found that 30% of unvaccinated people said they were waiting for COVID-19 vaccines to receive full approve before taking the next step to get vaccinated. A joint statement from the AMA, American Hospital Association and American Nurses Association states, “We are there now. This vaccine is fully approved. If uncertainty was holding you back, now is the time to act.”
Video Series: Communicating about Vaccines: Offers a series of short videos to help public health advocates, staff in local health departments, and others communicate more effectively about COVID-19 and how it intersects with other important public health issues. In the initial (4 minutes) video, Berkeley Media Studies Group [BMSG] offers strategic communication tips by investing in trusted messengers.
COVID-19 Vaccine Breakthrough Cases: Data from the States: Provides state-level data on COVID-19 breakthrough cases, hospitalizations and deaths. While COVID-19 vaccines are highly effective, a small share of fully vaccinated individuals do become infected. These rare “breakthrough cases” are expected, as no vaccine is 100% effective. While the Centers for Disease Control and Prevention [CDC] presents aggregate data at the national level, this Kaiser Family Foundation site serves as a single repository for data by state on breakthrough infections that can support data-based decision-making indicated by federal guidance for schools and communities. The Kaiser Family Foundation’s Vaccine Monitor presents data from an ongoing research project tracking the public’s attitudes and experiences with COVIED-19 vaccinations.
States Plan for Vaccinating Their Populations against COVID-19: Provides a compendium of every state’s COVID-19 vaccination distribution and administration plans by Priority Phases, in light of current (2/19/21) federal guidance, and limited vaccine supplies. This state-by-state compendium is compiled and updated by the National Academy for State Health Policy [NASHP].
Tracking COVID-19 Vaccine Distribution by State: How Many People Have Been Vaccinated in the US?: Synthesizes and displays data originating at the Centers for Disease Control and Prevention [CDC] accounting for distribution and administration of doses of all three authorized vaccines (those made by Pfizer-BioNTech, Moderna, and Johnson & Johnson). The presentation is made and updated (11/01/21) by USA Today.
Understanding and Communicating about COVID-19 Vaccine Efficacy, Effectiveness, and Equity: Summarizes social, behavioral, and decision science research relevant to communicating how well COVID-19 vaccines work, and how equitably they are being distributed. It offers practical strategies for both the process and the content of such communication, recognizing that people respond to both how they learn about something and what they learn about it. This rapid expert consultation was produced through the Societal Experts Action Network [SEAN] of the National Academies of Sciences, Engineering, and Medicine in affiliation with U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response.
New Tool Tracks Vaccination and Vaccine Hesitancy Rates Across Geographies, Population Groups: Uses data from the U.S. Census Bureau’s Household Pulse Survey, which has recently added a new series of questions about COVID-19 vaccinations and attitudes toward them. This new Census Bureau data visualization tool aims to provide insights into the public’s feelings about COVID-19 vaccines in near real time. The interactive visualization allows data users to explore national and state vaccination rates; percentage of people by state hesitant to get a COVID-19 vaccine; most common reasons cited for hesitancy to get a vaccine; vaccination rates by population subgroups; and vaccine hesitancy rates by population subgroups. The data visualization tools will enable analysis of how vaccination and vaccine hesitance rates might vary over time.
Public Health Messaging Vital for COVID-19 Vaccine Uptake: Leaders Partnering on Communications: Reports re